TITLE

Salvage or savage chemotherapy for poor-risk or relapsed testis cancer—20 years later, not much has changed

AUTHOR(S)
Raghavan, D.
PUB. DATE
April 2012
SOURCE
Annals of Oncology;Apr2012, Vol. 23 Issue 4, p813
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
74074042

 

Related Articles

  • Treatment of testicular intraepithelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: A survey of the German Testicular Cancer Study Group. Dieckmann, K.-P.; Wilken, S.; Loy, V.; Matthies, C.; Kleinschmidt, K.; Bedke, J.; Martinschek, A.; Souchon, R.; Pichlmeier, U.; Kliesch, S. // Annals of Oncology;May2013, Vol. 24 Issue 5, p1332 

    Background The treatment of testicular intraepithelial neoplasia (TIN), the progenitor of testicular germ cell tumours (GCTs), is based on little data. Patients and methods Two hundred and twenty-eight GCT patients with contralateral TIN were retrospectively enrolled. Ten had surveillance, 122...

  • A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer. Nakai, Yousuke; Isayama, Hiroyuki; Sasaki, Takashi; Takahara, Naminatsu; Hamada, Tsuyoshi; Uchino, Rie; Mizuno, Suguru; Miyabayashi, Koji; Yamamoto, Keisuke; Mohri, Dai; Kogure, Hirofumi; Yamamoto, Natsuyo; Hirano, Kenji; Ijichi, Hideaki; Tateishi, Keisuke; Tada, Minoru; Koike, Kazuhiko // Cancer Chemotherapy & Pharmacology;Dec2013, Vol. 72 Issue 6, p1291 

    Purpose: In salvage chemotherapy for refractory pancreatic cancer, early assessment is important to avoid unnecessary toxicities from ineffective chemotherapy. Early CA19-9 change after the first course as a prognostic factor was evaluated in this setting. Methods: Patients receiving salvage...

  • Chemotherapy or Targeted Therapy as Second-Line Treatment of Advanced Gastric Cancer. A Systematic Review and Meta-Analysis of Published Studies. Iacovelli, Roberto; Pietrantonio, Filippo; Farcomeni, Alessio; Maggi, Claudia; Palazzo, Antonella; Ricchini, Francesca; de Braud, Filippo; Di Bartolomeo, Maria // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less than 60% of patients receive salvage therapy in clinical practice. We performed a systematic review and meta-analysis based on trial data on the role of second-line treatment of advanced gastric cancer....

  • Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma? Bekku, Kensuke; Saika, Takashi; Kobayashi, Yasuyuki; Kioshimoto, Ryo; Kanbara, Taiki; Nasu, Yasutomo; Kumon, Hiromi // International Journal of Clinical Oncology;Feb2013, Vol. 18 Issue 1, p110 

    Background: The clinical impact of salvage surgery after chemotherapy on cancer survival of patients with metastatic urothelial carcinoma is controversial. We aimed to verify the clinical role of salvage surgery by analyzing the long-term outcome in patients with urothelial carcinoma treated by...

  • Advanced ovarian cancer: what should be the standard of care? Goff, Barbara A. // Journal of Gynecologic Oncology;Mar2013, Vol. 24 Issue 1, p83 

    The standard treatment of advanced ovarian cancer is rapidly changing. As we begin to understand that epithelial ovarian cancer is a heterogeneous disease, our treatment strategies are evolving to include novel biologic drugs that specifically exploit altered pathways. Surgery remains an...

  • Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Wink, Krista C. J.; Roelofs, Erik; Lambin, Philippe; Troost, Esther G. C.; Solberg, Timothy; Lin, Liyong; Simone II, Charles B.; Jakobi, Annika; Richter, Christian // Frontiers in Oncology;Oct2014, Vol. 4, p1 

    This review article provides a systematic overview of the currently available evidence on the clinical effectiveness of particle therapy for the treatment of non-small cell lung cancer and summarizes findings of in silico comparative planning studies. Furthermore, technical issues and dosimetric...

  • Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients. Yoshino, Kiyoshi; Enomoto, Takayuki; Fujita, Masami; Ueda, Yutaka; Kimura, Toshihiro; Kobayashi, Eiji; Tsutsui, Tateki; Kimura, Tadashi // International Journal of Clinical Oncology;Feb2013, Vol. 18 Issue 1, p148 

    Background: Recurrent or persistent clear cell carcinoma (CCC) of the ovary is particularly chemotherapy resistant. The purpose of this study was to review our extensive institutional experiences with recurrent or persistent CCC with the aim of finding a more effective chemotherapy regimen....

  • Another Test in Life.  // American Family Physician;8/1/2014, Vol. 90 Issue 3, p1 

    A personal narrative is presented which explores the author's experience of being diagnosed with testicular cancer and undergoing chemotherapy, along with a physician's commentary on testicular cancer.

  • Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis. Fitzgerald, John P.; Ercole, Barbara; Parekh, Dipen J. // Indian Journal of Urology;Jan2010, Vol. 26 Issue 1, p98 

    The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics